Access to Natural Space Can Limit Hospital Stays With Parkinson’s
Older adults with Parkinson’s disease who live in areas with more greenery, parks, or surface water are less likely…
Articles by Marisa Wexler, MS
Sleep Benefit May Be Explained by ‘Direct Neurochemical Evidence’
Sleep benefit — a poorly understood phenomenon where people with Parkinson’s disease have fewer symptoms upon waking up —…
StimFit Algorithm May Help Speed Process of Personalizing DBS Settings
An automated algorithm called StimFit may help speed up the time to finding optimal settings of deep brain stimulation…
Parkinson’s Clinical Trial Simulators Win Support of Regulators in EU
The European Medicines Agency (EMA) has issued a letter in support of model-based clinical trial simulators for Parkinson’s disease…
Study Challenges View of How Alpha-synuclein Drives Parkinson’s
Alpha-synuclein clumps’ toxic effects — a hallmark of Parkinson’s disease — are independent of the production of the protein…
Trial of Supplement Nicotinamide Riboside to Include Extension Study
An open-label extension study has been launched for NOPARK, a placebo-controlled Phase 2 clinical trial that’s assessing the effectiveness of…
Incidence of Parkinson’s in US More Than Previously Estimated
Nearly 90,000 people, 65 or older, are diagnosed with Parkinson’s disease every year in the U.S., representing an increase…
Groups to Use Wearable Technology to Predict Parkinson’s Progression
Clinical Ink is partnering with a “leading biopharmaceutical organization” to monitor symptoms of people with Parkinson’s disease at…
Trial of Mesdopetam for Levodopa-induced Dyskinesia Nears End
Top-line results are expected next month from a Phase 2b clinical trial testing whether the investigational oral therapy mesdopetam can…
Nitrase, HitGen Join to Discover Potential of Nitrase Enzymes
Nitrase Therapeutics has partnered with HitGen in the search for novel therapies that suppress nitrases, a class of…